Pamrevlumab for Idiopathic Pulmonary Fibrosis
This randomized clinical trial compares the efficacy and safety of pamrevlumab vs placebo for patients with idiopathic pulmonary fibrosis.
Source: jamanetwork.com
Eisai Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Eisai Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Eisai Pharma Today - Breaking & Trending Today
National News: 'State received COVID donations worth ₹57 crore'
‘State received COVID donations worth ₹57 crore’ : Rashtra News #State #received #COVID #donations #worth #crore The State had received COVID-related donations worth ₹57 crore so far from various individuals and organisations across the world, said COVID-19 nodal officer Arja Srikanth.Dr. Srikanth, in a release, said that of the ₹57 crore worth of donations received,
Source: rashtranews.com
Bellevue Asset Management AG: Emerging Markets Healthcare sector comeback
DJ Bellevue Asset Management AG: Emerging Markets Healthcare sector comeback Bellevue Asset Management AG / Key word(s): Market Report Bellevue Asset Management AG: Emerging Markets Healthcare sector
Source: finanznachrichten.de